M

Montefiore Einstein

Hospital and health care provider

Physician Assistant

Full-Time
$76.52/hr
Junior, Mid
Master's
Bronx, NY, USA
In Person
Medical, Clinical & VeterinaryAdvanced Practice Providers

About the job

Requirements
  • A master's degree is required.
  • A New York State Physician Assistant license and registration are required.
  • One to three years of experience working with cancer patients is required, including prior experience in clinical trials and grant-funded projects.
  • Excellent interpersonal skills are required for interaction with participants.
  • An Occupational Health Services fit test is required.
  • An Occupational Health Services annual assessment is required.
  • A Basic Life Support card is required.
Responsibilities
  • Review patient histories, conduct physical examinations, and manage the medical care of cancer patients enrolled in early-phase clinical trials, including treatment and supportive care.
  • Maintain protocol and Good Clinical Practice compliance.
  • Explain study participation, including potential treatment options, treatment alternatives, and expected and unexpected medication side effects.
  • Assess patients on early-phase clinical trials, including reviewing medical history, review of systems, and complaints; assess adverse events; and manage adverse events in accordance with scope of practice and protocol requirements.
  • Support the physician or medical director so that the Early Phase Research Program enrolls and treats patients efficiently and in an integrated manner.
  • Take appropriate patient notes and ensure patient care is logged in the electronic health record.
  • Use patient information to develop teaching and long-term plans, and document and evaluate patients' and involved others' responses to that teaching and planning.
  • Collaborate and communicate with clinical and clinical research team members to create an integrated medical treatment plan for each early-phase clinical-trial participant.
  • Write appropriate medical orders for registered nurses to execute and ensure orders and documentation meet required standards.
Desired Qualifications
  • Experience with therapeutic research is preferred.
  • Bilingual Spanish language skills are preferred.

About the company

Montefiore Einstein is a major hospital-and-healthcare network in the Bronx that provides medical care through its hospital and outpatient facilities. It combines clinical services with education and research through its affiliation with the Albert Einstein College of Medicine, offering inpatient and outpatient care, diagnostics, specialty treatments, and community health programs. Its care model centers on teams of doctors, nurses, and other clinicians using integrated systems to diagnose, treat, and manage patients. The partnership with Einstein differentiates it by linking patient care with medical teaching and research, enabling clinical trials and innovations to flow from the lab to the bedside. The goal is to deliver comprehensive, high-quality health care, advance medical knowledge through research and education, and improve health outcomes for the communities it serves.

Company Size

1,001-5,000

Company Stage

N/A

Total Funding

$4.9M

Headquarters

New York City, New York

Founded

N/A

Get referred to Montefiore Einstein

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • June 9, 2026 brought Montefiore One Medical’s first New York specialty-site office in Elmsford.
  • May 28, 2026 grants added $8 million for HERO Dads programming and scale.
  • Einstein received more than $192 million NIH awards in 2024, sustaining lab momentum.

What critics are saying

  • July 2026 AI layoffs cut 12 utilization-review nurses across Moses, Einstein, and Weiler campuses.
  • NYSNA filed a class-action grievance after Montefiore’s May 28, 2026 notices.
  • Persistent AI labor conflict triggers departures and breaks Montefiore's Bronx service network.

What makes Montefiore Einstein unique

  • Albert Einstein College of Medicine feeds Montefiore’s 10-hospital academic engine and NIH-backed research.
  • MECCC is NCI-designated, and Ulrich Steidl took leadership on April 7, 2026.
  • Amazon One Medical integration gives Montefiore specialty access across Manhattan and Westchester.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Health Insurance
  • Dental Insurance
  • Vision Insurance
  • Paid Vacation
  • Paid Holidays
  • Paid Sick Leave
  • Health Savings Account/Flexible Spending Account
  • Tuition Reimbursement
  • Gym Membership
  • Life Insurance
  • Training Programs
  • Conference Attendance Budget

Company News

MarketScreener
Oct 19th, 2026
ATyr Pharma, Inc. announces research collaboration with Albert Einstein College of Medicine and Montefiore Einstein.

ATyr Pharma, Inc. announces research collaboration with Albert Einstein College of Medicine and Montefiore Einstein. Published on 10/19/2026 at 01:50 pm EDT S&P Capital IQ aTyr Pharma, Inc. announced a research collaboration with Albert Einstein College of Medicine to further the development and testing of ATYR2810, the Company?s monoclonal antibody that targets the neuropilin-2 (NRP2) receptor. The collaboration will be led by Bang H. Hoang, M.D., Arnold and Madaleine Penner Professor and Co-Director of Orthopaedic Oncology in the Department of Orthopaedic Surgery at Montefiore Einstein. Dr. Hoang?s research focuses on the pathophysiology and molecular mechanisms of bone and soft tissue cancer, including evaluating the role of NRP2 in pediatric bone cancers such as osteosarcoma. ATYR2810 has demonstrated anti-tumor effects in multiple preclinical models, including non-small cell lung cancer, triple-negative breast cancer, renal cell carcinoma and glioblastoma. These findings have been presented at scientific conferences, including the American Academy of Cancer Research, and published in a landmark publication in Science Translational Medicine. (C) S&P Capital IQ - 2026

PR Newswire
Oct 15th, 2026
Newly established cancer leadership roles bring promise to the future of research and care.

Newly established cancer leadership roles bring promise to the future of research and care. Oct 15, 2026, 11:20 ET Montefiore Einstein Comprehensive Cancer Center Appoints Senior Leaders to Advance Research and Programs Spanning Basic, Translational, Clinical, and Population Science BRONX, N.Y., Oct. 15, 2026 /PRNewswire/ - Ulrich Steidl, M.D., Ph.D., has finalized his Montefiore Einstein Comprehensive Cancer Center (MECCC) senior leadership team, just six months after stepping into the role of MECCC Director and Vice President of Cancer Medicine at Montefiore Einstein. "Today marks a new chapter as we elevate elite colleagues who have significant research accomplishments and leadership experience to principal posts at MECCC," said Dr. Steidl. "They are recognized "all-stars" in their fields, and together, working at one of the nation's top cancer centers, we will move the needle in not just helping people survive advanced cancers but identifying the factors that drive certain cancers from occurring in the first place." "All-Stars" in Cancer Research & Familiar Faces to the Bronx Community * Amit K. Verma, M.D., M.B.B.S., who was named Chair, Medical Oncology at Montefiore Einstein earlier this year, moved from Associate Director to Deputy Director of MECCC. Dr. Verma is a leader in the study and treatment of myeloid malignancies, such as myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML), and Dr. Verma was part of the team that first defined stem cell alterations in MDS and AML. He also led research that discovered the key role of several signaling pathways that are critical to the development of MDS. These findings directly resulted in an FDA-approved novel therapy for MDS. Most recently, Dr. Verma earned an "All-Star" Grant from the V Foundation for his ability to drive transformative projects that can significantly advance cancer research and treatment. He was also elected to the Association of American Physicians (AAP), an honor extended to physicians with outstanding credentials in basic or translational biomedical research. * Julio A. Aguirre-Ghiso, Ph.D., is now Associate Director, Basic Science. Dr. Aguirre-Ghiso, who also serves as Director of MECCC's Cancer Dormancy Institute, is an internationally recognized cancer biologist who recently earned the Metastasis Research Society's highest honor for his substantial advancements in understanding cancer metastasis. He has helped lead a major shift in the cancer biology field by investigating how cancer cells hibernate undetected for long periods of time and what causes them to suddenly awaken to seed deadly, treatment-resistant metastases. He brings his deep scientific expertise in cancer biology and natural curiosity to help stimulate tomorrow's medical breakthroughs. * Marina Konopleva M.D., Ph.D., now Associate Director, Translational Science, is also Co-Director of the Blood Cancer Institute and Director of the Leukemia Program at Montefiore Einstein. She is internationally recognized for her transformational research on proteins that can help leukemia cells evade their natural death signals and how to target these same proteins to make cancer cells more vulnerable to treatment. Her discoveries and translational research have had clinical practice-changing impact in the treatment of myeloid leukemias and other cancers, and led to FDA approval of novel cell death-stimulating drugs. Dr. Konopleva is an elected member of the AAP and has been selected as the recipient of the highly prestigious 2026 Ernest Beutler Prize in Clinical Science by the American Society of Hematology. She will continue spearheading efforts to turn basic laboratory discoveries into clinical treatments that can advance the health of MECCC's patients. Community Engagement at the Forefront Dr. Steidl and his team have also developed a senior leadership position to strengthen research on associations between environmental exposures, health related social needs, and cancer health outcomes. H. Dean Hosgood, Ph.D., Co-Leader of MECCC's Cancer Epidemiology Prevention & Control Program and now Associate Director for Population and Community Sciences has been appointed to lead this effort. Dr. Hosgood is formally trained in environmental epidemiology, cancer epidemiology, and molecular epidemiology. He currently leads a global consortium to investigate how indoor air pollutants - caused from the burning of coal or wood for heating and cooking - are associated with lung cancer mortality and result in an increased risk for other cancers. His research on the interactions between genetics and environmental exposures have appeared in more than 250 peer-reviewed publications. Rounding out the impressive list, Wenjun Guo, Ph.D., will now serve as Co-Leader of the Tumor Microenvironment & Metastasis program, alongside Maja H. Oktay, M.D., Ph.D., and Dr. Aguirre-Ghiso, Ph.D. Aditi Shastri, M.D., has joined Steven Almo, Ph.D., and Evripidis Gavathiotis, Ph.D., as co-leader of MECCC's Cancer Therapeutics Program, developing precision drugs and cellular therapies. For more than 50 years, MECCC has been at the forefront of care and community engagement with novel research and transdisciplinary initiatives, including its Tumor Microenvironment and Metastasis, Stem Cell and Cancer Biology, Cancer Therapeutics, and Cancer Epidemiology, Prevention and Control programs. MECCC patients also benefit from services like its nationally lauded Bronx Oncology Living Daily program which supports patients and families impacted by cancer through peer navigators as well as wellness workshops like yoga, reiki, and creative arts. About Montefiore Einstein Comprehensive Cancer Center Montefiore Einstein Comprehensive Cancer Center (MECCC) is a National Cancer Institute (NCI)-designated comprehensive cancer center and a national leader in cancer research and care located in the Bronx, N.Y. MECCC combines the exceptional science of Albert Einstein College of Medicine with the multidisciplinary and team-based approach to cancer clinical care at Montefiore Health System. Founded in 1971 and an NCI-designated cancer center since 1972, MECCC is redefining excellence in cancer research, clinical care, education and training, and community outreach and engagement. Its mission is to reduce the burden of cancer for all. SOURCE Montefiore Einstein Comprehensive Cancer Center

PR Newswire
Oct 15th, 2026
Montefiore Einstein introduces newly renovated labor & delivery suite at Jack D. Weiler Hospital.

Montefiore Einstein introduces newly renovated labor & delivery suite at Jack D. Weiler Hospital. Oct 15, 2026, 07:02 ET The Project Was Funded by a $9.68 Million New York Statewide Health Care Facility Transformation Program Fund BRONX, N.Y., Oct. 15, 2026 /PRNewswire/ - Elected officials and Montefiore Einstein staff proudly unveiled a newly renovated labor and delivery (L&D) suite at Jack D. Weiler Hospital. Funded by a $9.68 million New York Statewide Health Care Facility Transformation Program grant, the Weiler Mother Baby Unit located on the sixth floor at 1825 Eastchester Road includes a redesigned workflow and capital upgrades to its L&D rooms, maternal surgical suite, and triage and waiting areas. "Our hospital is the only regional perinatal center in the Bronx, taking care of the highest risk pregnancies across the Bronx and part of Queens," said Angela Gonzalez-Perez, MPA, FACHE, Vice President of Operations and Executive Director, Jack D. Weiler Hospital. "It was of the utmost importance for us to ensure that our patients experience a warm, welcoming environment where they can receive the finest care possible. Thanks to the tremendous support from New York State, this newly renovated space serves as the physical embodiment of our vision of being a premier academic medical center that transforms health and enriches lives." Enhancing Experiences for Bronx Patients The modernized Unit includes state-of-the-art upgrades to L&D rooms with ensuite bathrooms; a reconfigured clinician team station and workflow; a modernized triage area with six triage bays and one evaluation triage bay; a modernized maternal surgical suite with a dedicated C-Section Post-Anesthesia Care Unit including four bays; and upgrades to the three Delivery Room Operating Rooms. Additionally, lighting has been enhanced throughout the Unit offering a more comfortable and soothing environment. Montefiore Einstein has also invested in remote monitoring tools to support the patients and clinical teams and is offering new food options to enhance the patient experience. Under the leadership of Mark H. Einstein, M.D., M.S., who became the Chella and Moise Safra Endowed Chair, Department Chair of Obstetrics & Gynecology and Women's Health in 2024, 26 new physicians specializing in areas including critical care obstetrics, adolescent medicine and onco-fertility, in addition to nurse practitioners and physician assistants have been on-boarded to support care. Services like universal depression screening in the hospital, collaborative care with reproductive psychiatry, a specialized postpartum outpatient clinic for individuals with medically complex or high-risk pregnancies, as well as a cardiac maternal medicine program also continue to grow. Dr. Einstein's leadership team has been instrumental in the design of the newly unveiled Unit. "With the new technology upgrades and redesigned workflows, we are equipped to take care of the most complex cases and do so in a beautiful new family friendly atmosphere," said Rodney Wright, M.D., Vice Chair, Obstetrics. "I couldn't be prouder to unveil this unit and continue growing our department and offerings to support our patients and their loved ones," said Mark H. Einstein, M.D., M.S., who is also a professor of Obstetrics & Gynecology and Women's Health (Gynecological Oncology) at Albert Einstein College of Medicine. The renovation of the L&D has been conducted in phases with no interruption to patient care. Five of the six phases are complete, with the final phase including renovations of the last two L&D rooms, plus a back service elevator upgrade, planned for completion in early 2027. SOURCE Montefiore Health System

PR Newswire
Oct 15th, 2026
Montefiore Einstein presents the newly renovated labor and delivery unit at Jack D. Weiler Hospital.

Montefiore Einstein presents the newly renovated labor and delivery unit at Jack D. Weiler Hospital. Oct 15, 2026, 07:02 ET The project was funded with $9.68 million from the New York State Health Care Facility Transformation Program BRONX, N.Y., October 15, 2026 /PRNewswire-HISPANIC PR WIRE/ - Various elected officials and members of Montefiore Einstein staff had the honor of presenting the newly renovated labor and delivery unit at Jack D. Weiler Hospital. The Weiler Maternal-Infant Unit - located on the sixth floor of 1825 Eastchester Road and funded through a $9.68 million grant from the New York State Health Care Facility Transformation Program - features a reorganization of workflows and infrastructure improvements in the labor and delivery rooms, the obstetric surgical area, and the triage and waiting areas. "Our hospital is the only regional perinatal center in the Bronx and cares for the highest-risk pregnancies throughout the Bronx and parts of Queens," explains Angela Gonzalez-Perez, MPA, FACHE, Vice President of Operations and Executive Director of Jack D. Weiler Hospital. "For us, it was a priority to ensure that our patients enjoyed a warm and welcoming environment where they could receive the best possible care. Thanks to the enormous support of New York State, this newly renovated space is the physical expression of our vision: to be a top-tier academic medical center that transforms health and improves people's lives." Better experiences for Bronx patients This modern unit incorporates state-of-the-art improvements in the labor and delivery rooms, which now have private bathrooms; a reorganized clinical team station and workflow; a modernized triage area with six triage stations and one assessment station, and a modernized obstetric surgical area with a post-anesthesia care unit (PACU) exclusively for cesarean sections equipped with four bays, as well as improvements in the three operating rooms of the labor and delivery unit. In addition, lighting throughout the unit has been improved to provide a warmer and more relaxing environment. Montefiore Einstein has also invested in remote monitoring instruments to support both patients and clinical teams, and offers new food options to improve the patient experience. Under the leadership of Mark H. Einstein, M.D., M.S. - who in 2024 held the Chella and Moise Safra Chair, as well as the chairmanship of the Department of Obstetrics, Gynecology and Women's Health - 26 new physicians specializing in areas such as critical care obstetrics, adolescent medicine, and oncofertility have been brought on board, along with advanced practice nurses (NPs) and physician assistants, to strengthen care. In addition, services such as universal hospital depression screening; collaborative reproductive psychiatry care; a postpartum outpatient clinic specializing in people with medically complex or high-risk pregnancies, and a maternal cardiology program continue to be strengthened. Dr. Einstein's leadership team has played a fundamental role in the design of this new unit. "Thanks to the new technological improvements and the reorganization of workflows, we are better prepared to handle the most complex cases, and to do so in a renovated, attractive, and welcoming environment for families," says Rodney Wright, M.D., Vice President of Obstetrics. "I am enormously proud to present this unit and to continue expanding our department and support services for our patients and their loved ones," says Mark H. Einstein, M.D., M.S., who is also a professor of Obstetrics, Gynecology and Women's Health (Gynecologic Oncology) at Albert Einstein College of Medicine. The renovation of the Labor and Delivery Unit was carried out in phases, which avoided having to interrupt patient care. Five of the six planned phases have already been completed. The last phase, expected to be completed in early 2027, will include the renovation of the last two labor and delivery rooms and the modernization of a service elevator located at the rear. Source Montefiore Health System

Montefiore Nyack Hospital
Aug 12th, 2026
Top left menu.

Top left menu. Nyack, NY, August 12, 2026 - Montefiore Nyack Hospital has earned the Leapfrog Full Transparency Badge, recognizing the hospital's commitment to publicly reporting information about patient safety and quality through the annual Leapfrog Hospital Survey. The Full Transparency Badge is awarded to hospitals that complete, affirm, and submit all sections of the Leapfrog Hospital Survey, one of the nation's leading voluntary reporting programs focused on patient safety, quality, and transparency. Trust begins with transparency, said Anthony Matejicka, DO, MPH, FACP, vice president, chief medical officer at Montefiore Nyack Hospital. Montefiore Nyack is deeply honored to be recognized by The Leapfrog Group for its commitment to sharing patient safety information and quality data openly with the community. This is not the first time The Leapfrog Group recognized Montefiore Nyack Hospital. Earlier this spring, The Leapfrog Group awarded the hospital with an A safety grade. In addition, the hospital earned accolades from US News & World Report as one of the best Home Care Agencies in 2026; and most recently, The American Heart Association presented the hospital with a Get With The Guidelines(R)- Stroke Gold Plus award for demonstrating its commitment to delivering evidence-based, life-saving stroke care. Castle Connolly also named Montefiore Nyack Hospital as a leader in patient care, earning a spot on the organization's Top Hospitals list for a New York State Procedure Award for General Surgery. Montefiore Nyack applaud Montefiore Nyack Hospital for its commitment to transparency, said Leah Binder, president and CEO of The Leapfrog Group. Transparency is one of the most powerful drivers of improvement in health care. By fully participating in the Leapfrog Hospital Survey, Montefiore Nyack Hospital is helping patients and families access meaningful information about the safety and quality of their care. The Leapfrog Full Transparency Badge appears on Leapfrog's public ratings website and identifies hospitals that have committed to openly sharing information about their performance. About Montefiore Nyack Hospital Montefiore Nyack Hospital is a 375-bed community acute care medical and surgical hospital founded in 1895. Its mission is to provide competent, innovative, and accessible emergency and acute care services to the residents of Rockland County, NY, and its surrounding areas. It is a member of Montefiore Health System and a partner with Albert Einstein College of Medicine and Touro College of Osteopathic Medicine, providing clinical rotations to medical students. To learn more, visit www.montefiorenyack.org; follow Montefiore Nyack on Facebook, X, LinkedIn, and Instagram; view Montefiore Nyack on YouTube. About The Leapfrog Group Founded in 2000 by large employers and other purchasers, The Leapfrog Group is an independent national nonprofit organization driving a movement for patient safety and transparency. Leapfrog collects, analyzes, and publicly reports data on hospital and ambulatory surgery center performance to help patients, purchasers, and other stakeholders make informed health care decisions. Leapfrog's flagship initiatives include the Leapfrog Hospital Safety Grade, a biannual letter grade focused exclusively on hospital safety, and the Leapfrog Hospital Survey, a voluntary survey that publicly reports hospital performance on patient safety and quality measures. Leapfrog's ratings and reports are peer-reviewed, fully transparent and free to the public. For more from Leapfrog, follow Montefiore Nyack on Twitter, LinkedIn, Facebook and Instagram and sign up for its newsletter.